This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fabris, B. Articles by Johnston, C. I. Search for Related Content PubMed PubMed Citation Articles by Fabris, B. Articles by Johnston, C. I.

Hypertension, Vol 17, 497-503, Copyright © 1991 by American Heart Association

ARTICLES

Salt blocks the renal benefits of ramipril in diabetic hypertensive rats

B Fabris, B Jackson and CI Johnston
University of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.

To establish if the benefit of angiotensin converting enzyme inhibitor therapy in retarding progressive diabetic renal injury is due to a specific intrarenal effect of the systemic hypotensive effect, we studied the effect of long-term ramipril treatment on blood pressure, glomerular filtration rate, and urinary protein excretion in streptozotocin-diabetic spontaneously hypertensive rats. The hypotensive effect of ramipril was prevented by a high salt diet, which did not alter the degree of renal angiotensin converting enzyme inhibition. Three weeks after uninephrectomy and induction of diabetes, rats were allocated to three groups. Groups 1 and 2 were given 1% NaCl, whereas group 3 was given water as drinking solution. One week later, groups 2 and 3 received 0.4 mg/kg/day ramipril in their drinking solution, which was continued over a 2-month period. Ramipril produced a blood pressure fall only in water-drinking rats (group 3) despite a similar reduction in plasma and renal angiotensin converting enzyme activity in groups 2 and 3. Salt-loaded rats had a progressive increase in urinary protein excretion over the duration of study. Ramipril treatment prevented an increase in protein excretion only in animals given water and with a reduced systolic blood pressure. Glomerular filtration rate was similar in all three groups. Ramipril treatment improved animal survival independently of a reduction in blood pressure or an effect on proteinuria. Although it is possible that angiotensin converting enzyme inhibitors have specific intrarenal effects reducing progression of diabetic proteinuria, concomitant control of systemic blood pressure appears to be necessary to demonstrate a benefit.

This article has been cited by other articles:

				C. A. Houlihan, T. J. Allen, A. L. Baxter, S. Panangiotopoulos, D. J. Casley, M. E. Cooper, and G. Jerums A Low-Sodium Diet Potentiates the Effects of Losartan in Type 2 Diabetes Diabetes Care, April 1, 2002; 25(4): 663 - 671. [Abstract] [Full Text] [PDF]

				T. Tikkanen, I. Tikkanen, M. D. Rockell, T. J. Allen, C. I. Johnston, M. E. Cooper, and L. M. Burrell Dual Inhibition of Neutral Endopeptidase and Angiotensin-Converting Enzyme in Rats With Hypertension and Diabetes Mellitus Hypertension, October 1, 1998; 32(4): 778 - 785. [Abstract] [Full Text] [PDF]

				K. C. Abbott, L. R. Sanders, and G. L. Bakris Microalbuminuria in Non--Insulin-Dependent Diabetes Mellitus: Implications for Renal Survival Arch Intern Med, January 24, 1994; 154(2): 146 - 153. [Abstract] [PDF]